Skip to content
NVEC

NVE Corporation

NVE Corporation Q2 FY2026 earnings call

October 22, 2025 · fiscal period ended 2025-09

EPS · actual vs est

$0.68 /

Revenue · actual vs est

$6.3M /
Ask about this call

Summary

Generated 2025-10-22

Management highlights

Financials

  • Revenue increased 4% QoQ, decreased 6% YoY; product sales up 1% YoY, nondefense up 21%, defense down 64%.
  • Gross margin decreased to 78% from 86% prior year due to less profitable product mix and distributor sales.
  • Total expenses decreased 7% in Q2 FY2026, R&D up 3%, SG&A down 23%.
  • Tax rate increased to 20% in Q2 FY2026, but full-year expected 16%-17% due to advanced manufacturing tax credits.
  • Net income for Q2 FY2026 was $3.31 million or $0.68 per diluted share.

New Equipment and R&D

  • Installed new equipment cluster, enabling wafer-level chip scale packaging in-house, expanding capacity and capabilities.
  • Launched 3 new products: rotation sensor, data coupler, wafer-level chip scale voltage regulator.

Trade Show and Annual Meeting

  • Exhibited at medical design and manufacturing trade show, highlighted products for medical devices.
  • Held annual shareholders meeting, reelected directors, approved compensation, and ratified auditor selection.
View in transcript ↓

Segment performance

Revenue increased 4% quarter-over-quarter sequentially and decreased 6% year-over-year. Year-over-year decrease was due to a 68% decrease in contract R&D revenue, partially offset by a 1% increase in product sales. Product sales saw a 21% increase in nondefense sales, while defense sales decreased 64%. Defense products sales were 8% of revenue, contract R&D was 3% of revenue. For the first 6 months of fiscal 2026, total revenue was $12.5 million, and net income was $6.89 million or $1.42 per diluted share.

View in transcript ↓

Guidance

Future Outlook

  • Expect to grow in the current (December) quarter, confident in long-term growth prospects.
  • Tax rate expected to be approximately 16%-17% for full year and next fiscal year due to advanced manufacturing investment tax credits.
  • Optimistic about growth in various markets including medical devices, industrial IoT, and robotics.
View in transcript ↓

Risks

Risks

  • Uncertainties related to economic environments in served industries.
  • Risks and uncertainties related to future sales and revenue.
  • Risks associated with tariffs, customs duties, and other trade barriers as listed in SEC filings.
View in transcript ↓

Q&A highlights

Q: Are we to expect growth in revenues from new equipment?

A: Part of the goal is to use new equipment to develop advanced products and fuel future growth, with growth already seen in sequential and nonmilitary sales.

Q: Is wafer scale packaging allowing a fully domestic supply chain?

A: Mostly domestic supply chain, with key operations in-house, though some materials still sourced overseas.

Q: Any potential in eVTOL market?

A: Significant advantages in power control for eVTOL, targeting Tier 1 and Tier 2 suppliers, optimistic about adding value to next-generation vehicles.

Q: Status of PUF market?

A: PUF market has volatility, nondefense sales strong, but PUF sales not a key growth driver currently.

Q: Impact of government shutdown on contract R&D?

A: Shutdown expected to be short-term, not too concerned, and confident in growth in current quarter

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS$0.68$0.83
Revenue$6.3M$6.8M

Transcript

October 22, 2025

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.